腾讯网13 小时
一文梳理：BRAF V600E 突变型 CRC 靶向、免疫有何进展？化疗价值如何？
BRAF V600E 突变在结直肠癌（CRC）中是一个重要的生物标志物，约占所有结直肠癌病例的 10%。这一突变通常与肿瘤的侵袭性、预后不良以及对常规化疗的耐药性相关联[1]。研究显示，BRAF V600E 突变导致肿瘤细胞激活 MAPK ...
thatsmags.com16 小时
24 Awesome Upcoming Events & Offers in the GBA
The annual Hong Kong Marathon is back for its 27th year and boasts the highest participation rate in Hong Kong, drawing thousands of local runners and elite athletes from around the world. The race ...